Specification of drug substances and products : development and validation of analytical methods /

Reviews in pharmaceutical and biomedical analysis
Wydane: (2010)

WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
Wydane: (2008)

WHO Expert Committee on Specifications for Pharmaceutical Preparations forty-first report.
Wydane: (2007)

Flow injection analysis of pharmaceuticals automation in the laboratory /
od: Martínez Calatayud, José
Wydane: (1996)

Biomedical chromatography
Wydane: (2010)

HPLC methods for recently approved pharmaceuticals
od: Lunn, George
Wydane: (2005)

Characterization of impurities and degradants using mass spectrometry
Wydane: (2011)

Dielectric analysis of pharmaceutical systems
od: Craig, Duncan Q. M.
Wydane: (1995)

Handbook of LC-MS bioanalysis best practices, experimental protocols, and regulations /
Wydane: (2013)

The selection and use of essential medicines
Wydane: (2006)

WHO Expert Committee on Biological Standardization fifty-sixth report.
Wydane: (2007)

WHO Expert Committee on Biological Standardization : sixtieth report /
Wydane: (2013)

Who Expert Committee on Biological Standardization : sixty-second report.
Wydane: (2013)

Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
od: Osmane, Malik
Wydane: (2014)

Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
od: Willig, Sidney H., 1919-
Wydane: (2000)

The war against counterfeit medicine my story /
od: Akunyili, Dora Nkem
Wydane: (2011)

Critical pathways to success in CNS drug development
Wydane: (2010)

WHO Expert Committee on Biological Standardization : sixty-third report. /
Wydane: (2014)

Continuous processing in pharmaceutical manufacturing /
Wydane: (2015)

Biological drug products : development and strategies /
Wydane: (2013)

Mass spectrometry in sports drug testing characterization of prohibited substances and doping control analytical assays /
od: Thevis, Mario, 1973-
Wydane: (2010)

Target validation in drug discovery
Wydane: (2006)

Advanced drug design and development a medicinal chemistry approach /
Wydane: (1994)

Formulation and analytical development for low-dose oral drug products
Wydane: (2009)

Drug design cutting edge approaches /
Wydane: (2002)

Substance misuse the implications of research, policy and practice /
Wydane: (2010)

Illicit drugs in the environment occurrence, analysis, and fate using mass spectrometry /
Wydane: (2011)

Stereoselective synthesis of drugs and natural products
Wydane: (2013)

Drug-drug interactions in pharmaceutical development
Wydane: (2008)

Drug and substance abuse in tertiary institutions in Kenya : a situational analysis /
Wydane: (2010)

On drugs
od: Lenson, David, 1945-
Wydane: (1995)

Substance withdrawal syndrome
Wydane: (2009)

Drug smugglers on drug smuggling lessons from the inside /
od: Decker, Scott H.
Wydane: (2008)

Substance abuse a global view /
Wydane: (2002)

The handbook of drugs and society /
Wydane: (2016)

Mass spectrometry in drug metabolism and disposition basic principles and applications /
Wydane: (2011)